BEIJING, May 20, 2013 (GLOBE NEWSWIRE) -- Dehaier Medical Systems Ltd. (Nasdaq:DHRM) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products, today announced that it entered into a strategic cooperation agreement with WideMed Ltd. (TASE:WDMD), a leading Israeli company engaged in the research, development and sale of innovative products for the growing bio-medical signal diagnostics and treatment market, to become WideMed's exclusive partner in China to market the Morpheus Ox System, a cost-effective, portable home sleep diagnostic and monitoring solution which enables to diagnose sleep disorders using a standard oximeter recording plethysmograph signal. The Signing Ceremony of Cooperation has been hold on May 20, 2013 and invited Mr. Matan Vilnai, The Israeli Ambassador to China, and also officials from Changping District of Beijing City to attend the ceremony. Dehaier will cooperate with WideMed to develop a new type watch-size device, which is designed to be integrated into existing Morpheus Ox platform. By collecting and recording the physiological data from the patients who wear watch-size device at home, the advanced automatic sleep scoring software is able to generate an accurate and reliable sleep study diagnosis, including Apnea Hypopnea Index (AHI), sleep/wake, and Cheyne-Stokes breathing. The new generation Morpheus Ox is going to be a comprehensive platform which manages a cost-effective sleep services operation, including patient electronic medical record, cardiac and sleep diagnostics outcomes and a complete workflow management. The web based automatic scoring and data management is able to facilitate operational efficiency and maximize growth potential, by way of providing its users valuable & timely clinical information to improve patient treatment. Moreover, it could also function as an enhanced Electronic Medical Record (EMR) clinical Database for hospitals. The system has passed the FDA and CE certificate, and is being prepared for SFDA registration.